Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ (26,210,844)	$ (12,446,458)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	2,334,739	921,379
Noncash interest expense	2,632,241	13,158
Noncash interest income	(87,233)	(21,479)
Stock compensation expense	316,086	372,870
(Gain) loss on sale of equipment	(100,000)	9,904
Gain on extinguishment of debt	(884,970)
Change in fair value of warrant liability	(517,680)	(67)
Impairment of right-of-use asset	101,838	520,759
Impairment of intangible assets	750,596
Changes in operating assets and liabilities, net of acquisition
Accounts receivable	438,284	(195,019)
Inventory	(410,341)	70,286
Other assets	1,152,200	577,193
Accounts payable	(481,453)	(503,516)
Accrued compensation and other liabilities	(1,559,881)	(818,433)
Deferred revenue	(870,114)	(6,016)
Net cash used in operating activities	(23,396,532)	(11,505,439)
Cash flows from investing activities
Acquisition of business net of cash acquired	1,266,849
Note receivable	(2,200,000)	(2,500,000)
Purchases of property and equipment	(130,354)	(31,826)
Proceeds from sale of equipment		29,250
Net cash used in investing activities	(1,063,505)	(2,502,576)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs	15,821,922	4,782,509
Proceeds from issuance of units and exercises of pre-funded warrants, net of selling costs		8,279,899
Proceeds from issuance of common stock and pre-funded warrants in private placement, net of selling costs	9,289,129
Proceeds from the exercise of common warrants	8,682,000
Proceeds from debt, net of issuance costs	1,871,308	470,519
Payments on debt	(998,182)	(828,850)
Payments on finance lease obligations	(579,029)	(535,931)
Net cash provided by financing activities	34,087,148	12,168,146
Effects of exchange rates on cash	1,586,541	(3,735)
Net increase (decrease) in cash, cash equivalents and restricted cash	11,213,652	(1,843,604)
Cash, cash equivalents and restricted cash at beginning of year	2,893,603	4,737,207
Cash, cash equivalents and restricted cash at end of year	14,107,255	2,893,603
Supplemental disclosure of cash flow information
Cash paid for interest	952,050	187,359
Supplemental disclosures of noncash investing and financing activities
Right-of-use assets acquired through operating leases	1,008,039
Right-of-use assets acquired through finance leases		528,413
Conversion of accounts payable to finance lease		63,600
Shares issued in business combination	4,847,417
Shares issued to settle convertible notes	1,450,797
Note receivable from sale of equipment included in other assets	$ 100,000